NCT01574248View on ClinicalTrials.gov

Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema

PHASE4TerminatedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2015

Study Completion Date

February 29, 2016

Conditions

ACE Inhibitor-associated Angioedema

Interventions

DRUG

icatibant

Subcutaneous at time 0 and 6 hours

OTHER

Placebo

Subcutaneous at time 0 and 6 hours

Trial Locations (2)

37235

Vanderbilt University Medical Center, Nashville

92093

University of California, San Diego, San Diego

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Shire

INDUSTRY

lead

Vanderbilt University Medical Center

OTHER